Biggest News Aggregation in the World
📰 All Ongoing News

All Ongoing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from All Ongoing. Real-time updates on events, politics, business and more.

Pharmanovia Enters In-Licensing Agreement With Axsome Therapeutics to Market and Further Develop Sunosi (solriamfetol), a First-In-Class Treatment for Excessive Daytime Sleepiness (EDS) in People With Narcolepsy and Obstructive Sleep Apnoea

The Agreement Covers All Existing Territories in Europe and Any Future Launches Across the Region Pharmanovia Will Also Lead All Activities to Support the Launch of Sunosi (solriamfetol) Across Middle
Dennis Riedl Herriot Tabuteau James Burt Alison Dyson Axsome Therapeutics Inc Agreement Covers All Existing Territories

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science